___

• 1. Imamura M, Cassius DA, Fregni F. Fibromyalgia: From treatment to rehabilitation. Eur J Pain. 2009;3:117-122.
• 2. Harris RE, Clauw DJ. Newer treatments for fibromyalgia syndrome. Ther Clin Risk Manag. 2008;4:1331-42.
• 3. Moldofsky H, Scarisbrick P, England R, et al.. Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositissyndrome” and healthy subjects. Psychosom Med 1975;37:341–51
• 4. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classifi cation of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis RheuM 1990; 33:160–72.
• 5. Gracely RH, Geisser ME, Giesecke T, et al. Pain catastrophizing and neural responses to pain among persons with fi bromyalgia. Brain 2004;127:835–43.
• 6. Kato K, Sullivan PF, Evengard B, et al. Importance of genetic influences on chronic widespread pain. Arthritis Rheum 2006a; 54:1682–6.
• 7. Raphael KG, Natelson BH, Janal MN, Nayak S. A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks. Pain. 2002;100:131-9.
• 8. McLean SA, Clauw DJ. Predicting chronic symptoms after an acute “stressor” – lessons learned from 3 medical conditions. Med Hypotheses 2004; 63:653–8.
• 9. Goldenberg DL, Burckhardt C, Crofford L. Management of fi bromyalgia syndrome. JAMA 2004; 292:2388–95.
• 10. Häuser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain. 2010;14:5-10.
• 11. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, Da Silva JA, Danneskiold-Samsøe B, Dincer F, Henriksson C, Henriksson KG, Kosek E, Longley K, McCarthy GM, Perrot S, Puszczewicz M, Sarzi-Puttini P, Silman A, Späth M, Choy EH; EULAR. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-41.
• 12. Lawson K. Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatr Dis Treat. 2008;4:1059-71.
• 13. Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fi bromyalgia. Pain Med 2007; 8:S63–S74.
• 14. Arnold LM, Keck PEJ, Welge JA. 2000. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000; 41:104–13.
• 15. Woolf CJ. Pain: moving from symptom control toward mechanismspecifi c pharmacologic management. Ann Intern Med 2004;140:441–51.
• 16. Clair A1, Emir B1. The safety and efficacy of pregabalin for treating subjects with fibromyalgia and moderate or severe baseline widespread pain. Curr Med Res Opin 2015; 22:1-30.
• 17. Busch AJ, Thille P, Barber KA, Schachter CL, Bidonde J, Collacott BK. Best practice: E-Model--prescribing physical activity and exercise for individuals with fibromyalgia. Physiother Theory Pract. 2008;2:151-66.
• 18. Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz CJ, Casimiro L, Robinson VA, McGowan J, Busch A, Poitras S, Moldofsky H, Harth M, Finestone HM, Nielson W, Haines-Wangda A, Russell- Doreleyers M, Lambert K, Marshall AD, Veilleux L; Ottawa Panel Members. Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther. 2008;88:857-71.
• 19. Rain C, Seguel W, Vergara L. Does exercise improve symptoms in fibromyalgia? Medwave. 2015;15:e6335. doi: 10.5867/medwave. 2015.6335
• 20. Lima MC, Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008;70:2329-37.
• 21. Itoh K, Kitakoji H. Effects of acupuncture to treat fibromyalgia: a preliminary randomised controlled trial. Chin Med. 2010;5:11.
• 22. Langhorst J, Klose P, Musial F, Irnich D, Häuser W. Efficacy of acupuncture in fibromyalgia syndrome--a systematic review with a meta-analysis of controlled clinical trials. Rheumatology (Oxford). 2010;49:778-88.
• 23. Baranowsky J, Klose P, Musial F, Häuser W, Dobos G, Langhorst J. Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia. Rheumatol Int. 2009;30:1-21.
• 24. Casale R, Tugnoli V. Botulinum toxin for pain. Drugs R D. 2008;9:11-27.
• 25. Smith HS, Audette J, Royal MA. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain. 2002;18:S147-54.
• 26. Häuser W, Arnold B, Eich W, Felde E, Flügge C, Henningsen P, Herrmann M, Köllner V, Kühn E, Nutzinger D, Offenbächer M, Schiltenwolf M, Sommer C, Thieme K, Kopp I. Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. Ger Med Sci. 2008;6:Doc14.
• 27. Ángel García D1, Martínez Nicolás I2, Saturno Hernández PJ. Clinical approach to fibromyalgia: Synthesis of Evidence-based recommendations, a systematic review Reumatol Clin. 2015;pii: S1699-258X(15)00110-2. doi: 10.1016/j.reuma.2015.06.001.
• 28. Castro-Sánchez AM, Matarán-Peñarrocha GA, Granero-Molina J, Aguilera-Manrique G, Quesada-Rubio JM, Moreno-Lorenzo C. Benefits of massage-myofascial release therapy on pain, anxiety, quality of , depression, and quality of life in patients with fibromyalgia. Evid Based Complement Alternat Med. 2011;2011:561753.
• 29. Ekici G, Bakar Y, Akbayrak T, Yuksel I. Comparison of manual lymph drainage therapy and connective tissue massage in women with fibromyalgia: a randomized controlled trial. J Manipulative Physiol Ther. 2009;32:127-33.
• 30. Donaldson MS, Speight N, Loomis S. Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med. 2001;1:7.